An orally delivered small-molecule formulation with antiangiogenic and anticancer activity

Vascular Biology Program and Department of Surgery, Children's Hospital Boston, Harvard Medical School, 1 Blackfan Circle, St. Karp Research Building, Boston, Massachusetts 02215, USA.
Nature Biotechnology (Impact Factor: 41.51). 08/2008; 26(7):799-807. DOI: 10.1038/nbt1415
Source: PubMed


Targeting angiogenesis, the formation of blood vessels, is an important modality for cancer therapy. TNP-470, a fumagillin analog, is among the most potent and broad-spectrum angiogenesis inhibitors. However, a major clinical limitation is its poor oral availability and short half-life, necessitating frequent, continuous parenteral administration. We have addressed these issues and report an oral formulation of TNP-470, named Lodamin. TNP-470 was conjugated to monomethoxy-polyethylene glycol-polylactic acid to form nanopolymeric micelles. This conjugate can be absorbed by the intestine and selectively accumulates in tumors. Lodamin significantly inhibits tumor growth, without causing neurological impairment in tumor-bearing mice. Using the oral route of administration, it first reaches the liver, making it especially efficient in preventing the development of liver metastasis in mice. We show that Lodamin is an oral nontoxic antiangiogenic drug that can be chronically administered for cancer therapy or metastasis prevention.

Download full-text


Available from: Avner Adini
  • Source
    • "Corneal Micropocket Assay. The corneal micropocket assay was performed as previously detailed (Benny et al., 2008). In brief, pellets containing 80 ng carrier-free recombinant human bFGF or 160 ng VEGF (R&D Systems, Minneapolis, MN) were implanted into micropockets that were created in the cornea of anesthetized mice. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obtustatin and Viperistatin, members of the disintegrin protein family, served as lead compounds or the synthesis of linear and cyclic peptides containing the KTS binding motif. The most active inear peptide, a Viperistatin analog, indicated the importance of Cys19 and Cys29, as well as the presence of Arg at position 24 for their biological activity, and was used as the basic sequence for the synthesis of cyclic peptides. Vimocin (Compound 6) and Vidapin (Compound 10), showed a high potency (IC50 0.17 nM) and intermediate efficacy (20% and 40%) in inhibition of adhesion of α1/α2 integrin overexpressor cells to respective collagens. Vimocin was more active in inhibition of the wound healing (53%) and corneal micropocket (17%) vascularization, while Vidapin was more potent in inhibition of migration in Matrigel tube formation assay (90%). Both compounds similarly inhibited proliferation (50-90%) of endothelial cells, and angiogenesis induced by VEGF (80%) and glioma (55%) in the chorioallantoic membrane assay. These peptides were not toxic to endothelial cell cultures and caused no acute toxicity upon iv injection in mice, and were stable for 10-30 hours in human serum. The in vitro and in vivo potency of the peptides are consistent with conformational ensembles and 'bio-active' space shared by Obtustatin and Viperistatin. These findings suggest that Vimocin and Vidapin can serve as a dual α1β1/α2β1 integrin antagonists in anti-angiogenesis and cancer therapy.
    Full-text · Article · Jun 2014 · Journal of Pharmacology and Experimental Therapeutics
  • Source
    • "In this study we investigate a potential therapy which has a mechanism of action distinct from the existing therapies. Lodamin, an oral polymeric formulation of TNP-470, is an irreversible inhibitor of MetAP2 [10]. MetAP2 has been recognized as a key target in angiogenesis [11]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic and recurrent uveitis account for approximately 10% of legal blindness in the western world. Autoimmune uveitis is driven by activated CD4(+) T cells that differentiate into effector T helper cells (Th1, Th2, and Th17) which release proinflammatory cytokines that damage the retina. In this study we investigated the effect of the methionine aminopeptidase 2 (MetAP2) inhibitor, Lodamin, on T cell activation and differentiation. MetAp2 is an enzyme which regulates cellular protein synthesis and is highly expressed in T cells. Lodamin was found to suppress T cell receptor (TCR) mediated T cell proliferation and reduced the production of Th1 and Th17 cells. Further, Lodamin suppressed overall inflammation in the mouse model of experimental autoimmune uveitis (EAU) by a six fold. This effect was attributed in part to a reduction in retinal proinflammatory cytokines, down regulation of MetAP2 expression in purified lymph node CD4(+) T cells, and a general normalization of the systemic immune reaction.
    Full-text · Article · Jun 2013 · PLoS ONE
  • Source
    • "nanoparticle colloidal properties (size, charge and PEG density) over interaction with A␤ 1–42 peptide (Fig. 1). To achieve this goal, we have selected poly(ethylene glycol)-block-polylactide (PEG-b- PLA) copolymer nanoparticles, which represent a widely employed class of nanocarriers for biomedical purposes (Benny et al., 2008). The colloidal features of the nanoparticles were modulated by playing with the nature of the surfactant, whereas the density of PEG chains displayed at the nanoparticle surface was finely tuned by using various PEG-b-PLA/PLA blend ratios during nanoparticle preparation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the extracellular deposition of amyloid-β peptides (Aβ). During the past few years, promising approaches based on nanotechnologies have emerged to alter Aβ aggregation and its related toxicity. This study aims to investigate the influence of the nanoparticle colloidal properties over the interaction with Aβ peptide 1-42 (Aβ(1-42)). Using capillary electrophoresis with laser-induced fluorescence detection, it was shown that biodegradable poly(ethylene glycol)-block-polylactide (PEG-b-PLA) nanoparticles were able to interact with Aβ(1-42) peptide leading to its uptake in rather short time periods. In addition, we highlighted the crucial role of the nanocarrier colloidal properties on the uptake kinetics. Whereas nanoparticles stabilized by sodium cholate (lower size and higher negative surface charge) gave optimum uptake kinetics, nanoparticles stabilized with others surfactants presented lower interactions. In contrast, PEG density seemed to have no influence on the interaction when sodium cholate was used for the preparation. This study intends to give new insights into Aβ(1-42) peptide interaction with nanoparticulate systems by helping to determine suitable nanoparticle characteristics regarding forthcoming therapeutic strategies against AD.
    Full-text · Article · Jul 2011 · Journal of Biotechnology
Show more